Literature Collection

Magnifying Glass
Collection Insights

12K+

References

11K+

Articles

1600+

Grey Literature

4800+

Opioids & SU

The Literature Collection contains over 11,000 references for published and grey literature on the integration of behavioral health and primary care. Learn More

Use the Search feature below to find references for your terms across the entire Literature Collection, or limit your searches by Authors, Keywords, or Titles and by Year, Type, or Topic. View your search results as displayed, or use the options to: Show more references per page; Sort references by Title or Date; and Refine your search criteria. Expand an individual reference to View Details. Full-text access to the literature may be available through a link to PubMed, a DOI, or a URL. References may also be exported for use in bibliographic software (e.g., EndNote, RefWorks, Zotero).

Enter Search Term(s)
Year
Sort by
Order
Show
158 Results
1
"The mediation and moderation effect of social support on the relationship between opioid misuse and suicide attempts among native American youth in New Mexico: 2009‑2019 Youth Risk Resiliency Survey (NM‑YRRS)": Correction
Type: Journal Article
Authors: Daniel Opoku Agyemang, Erin Fanning Madden, Kevin English, Kamilla L. Venner, Rod Handy, Tejinder Pal Singh, Fares Qeadan
Year: 2022
Topic(s):
Healthcare Disparities See topic collection
2
2024 National Strategy for Suicide Prevention
Type: Web Resource
Authors: U.S. Department of Health and Human Services
Year: 2024
Publication Place: Washington, D.C.
Topic(s):
Healthcare Policy See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

3
2024 National Strategy for Suicide Prevention Federal Action Plan
Type: Web Resource
Authors: U.S. Department of Health and Human Services
Year: 2024
Publication Place: Washington, D.C.
Topic(s):
Healthcare Policy See topic collection
,
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

4
2024 National Veteran Suicide Prevention Annual Report
Type: Web Resource
Authors: United States Department of Veterans Affairs
Year: 2024
Publication Place: Washington, D.C.
Topic(s):
Healthcare Disparities See topic collection
,
Grey Literature See topic collection
,
Opioids & Substance Use See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

5
A hidden epidemic: Suicide in the elderly and how we can help
Type: Journal Article
Authors: Lia Jessica, Erikavitri Yulianti
Year: 2025
Topic(s):
Healthcare Disparities See topic collection
6
A Prioritized Research Agenda for Suicide Prevention: An Action Plan to Save Lives
Type: Government Report
Authors: National Action Alliance for Suicide Prevention: Research Prioritization Task Force
Year: 2014
Publication Place: Rockville, MD
Topic(s):
Grey Literature See topic collection
Disclaimer:

This grey literature reference is included in the Academy's Literature Collection in keeping with our mission to gather all sources of information on integration. Grey literature is comprised of materials that are not made available through traditional publishing avenues. Often, the information from unpublished resources can be limited and the risk of bias cannot be determined.

7
A virtual, pilot randomized trial of a brief intervention to prevent suicide in an integrated healthcare setting
Type: Journal Article
Authors: N. B. Riblet, L. Kenneally, S. Stevens, B. V. Watts, J. Gui, J. Forehand, S. Cornelius, G. S. Rousseau, J. C. Schwartz, B. Shiner
Year: 2022
Abstract:

OBJECTIVE: Patients who die by suicide are often seen in primary care settings in the weeks leading to their death. There has been little study of brief interventions to prevent suicide in these settings. METHOD: We conducted a virtual, pilot, randomized controlled trial of a brief suicide prevention strategy called Veterans Affairs Brief Intervention and Contact Program (VA BIC) in patients who presented to a primary care mental health walk-in clinic for a new mental health intake appointment and were at risk for suicide. Our primary aim was to assess feasibility. We measured our ability to recruit 20 patients. We measured the proportion of enrolled patients who completed all study assessments. We assessed adherence among patients assigned to VA BIC. RESULTS: Twenty patients were enrolled and 95% (N = 19) completed all study assessments. Among the 10 patients assigned to VA BIC, 90% (N = 9) of patients completed all required intervention visits, and 100% (N = 10) completed ≥70% of the required interventions visits. CONCLUSION: It is feasible to conduct a virtual trial of VA BIC in an integrated care setting. Future research should clarify the role of VA BIC as a suicide prevention strategy in integrated care settings using an adequately powered design. CLINICAL TRIAL REGISTRATION: NCT04054947.

Topic(s):
Healthcare Disparities See topic collection
8
ACTively Integrating Suicide Risk Assessment Into Primary Care Settings
Type: Journal Article
Authors: H. A. Finnegan, C. N. Selwyn, J. Langhinrichsen-Rohling
Year: 2018
Publication Place: United States
Topic(s):
Education & Workforce See topic collection
9
Adaptation of an evidence-based, preventive intervention to promote mental health in Hispanic adolescents: eHealth Familias Unidas Mental Health
Type: Journal Article
Authors: T. Perrino, A. Lozano, Y. Estrada, M. I. Tapia, C. H. Brown, V. E. Horigian, W. R. Beardslee, G. Prado
Year: 2024
Abstract:

Youth internalizing symptoms (i.e., depression and anxiety), suicide ideation and attempts have been rising in recent years, including among Hispanics. Disparities in mental healthcare are concerning and require intervention, ideally prevention or early intervention. Familias Unidas is a culturally-syntonic, family-centered intervention effective in reducing youth drug use and sexual risk, with evidence of unanticipated effects on internalizing symptoms. This paper describes the systematic process used to adapt the eHealth version of the Familias Unidas intervention to more directly address internalizing symptoms and suicide risk in preparation for an effectiveness-implementation hybrid trial for youth with elevated internalizing symptoms, a history of suicide ideation/attempts, or poor parent-youth communication. The resulting eHealth Familias Unidas Mental Health intervention is described. Guided by a 4-phase framework, the steps in the adaptation process involved: assessment of the community and intervention delivery setting (pediatric primary care clinics); integration of previous intervention research, including intervention mechanisms of action; and expert and community consultation via focus groups. Focus group analyses showed that youth and parents perceived that the intervention was helpful. Their feedback was categorized into themes that were used to directly target mental health by addressing technology use, parent mental health, and social support. Effective and scalable preventive interventions are needed to address mental health disparities. The systematic adaptation process described in this paper is an efficient approach to expanding interventions while maintaining known, empirical and theoretical mechanisms of action. Findings from the ongoing effectiveness-implementation trial will be critical.; Mental health symptoms and suicide ideation and attempts have been increasing for several years. Disparities in quality and access to mental healthcare indicate that Hispanic and socioeconomically disadvantaged youth need accessible and targeted interventions, ideally preventive and early interventions. Our team adapted an existing, evidence-based prevention program for Hispanic families to specifically and directly address youth mental health to be delivered in primary healthcare settings. This paper describes the adaptation framework and steps taken to adapt the original program that was developed and tested for drug use and sexual risk behaviors, with the purpose of additionally addressing depression, anxiety, and suicide ideation and attempts. We subsequently describe the adapted program- eHealth Familias Unidas Mental Health- and discuss how it is currently being implemented and evaluated in primary healthcare settings. The paper provides information and an example of how other research teams can systematically adapt an intervention using insights from the peer-reviewed literature, participants, primary care clinic staff, and experts in youth mental health.; eng

Topic(s):
Healthcare Disparities See topic collection
,
HIT & Telehealth See topic collection
10
Addiction Severity Index in a chronic pain sample receiving opioid therapy
Type: Journal Article
Authors: K. Saffier, C. Colombo, D. Brown, M. P. Mundt, M. F. Fleming
Year: 2007
Publication Place: United States
Abstract: The treatment of chronic pain with opioids remains controversial. Physicians are concerned about addiction and drug diversion, and there is limited empirical information on the use of opioids in patients with chronic pain. This report presents data on the Addiction Severity Index (ASI) collected in a sample of patients (N = 908) receiving opioids from their primary care physicians. The ASI provides clinically important information about patients receiving opioid therapy. The ASI consists of seven subscales, including medical, alcohol, drug, employment/support, legal, family/social, and psychiatric domains. Clinically relevant findings include high ASI medical score (0.87), high psychiatric severity score (0.27), lifetime treatment of alcohol problems (reported by 22% of men), prior delirium tremens (5.6%), prior treatment for drug problems (10.1%), prior drug overdose (12.1%), and drunk-driving citations (28%); 40.3% of women had serious suicidal thoughts, and 23.8% had suicide attempts. The ASI provides important information that can help primary care physicians manage patients with chronic pain who are receiving opioid therapy.
Topic(s):
Opioids & Substance Use See topic collection
,
Measures See topic collection
11
Addressing Suicidality in Primary Care Settings
Type: Journal Article
Authors: J. M. Bostwick, S. Rackley
Year: 2012
Abstract: By design or by default, primary care providers (PCPs)are frequently the vanguard in the fight against suicide. Recent studies have highlighted programs to improve screening and prevention of suicidality in the medical home, particularly among high-risk patients, such as adolescents, the elderly, and veterans. Increasing efforts are also being paid to improving the PCP's skill in assessing for suicidality. However, it is becoming increasingly apparent that screening alone will not significantly lower suicide rates until it occurs within a well-integrated system that facilitates timely referral to more intensive mental health services for those patients who need them. Unfortunately, such systems are sorely lacking in many, if not most, areas of the USA.
Topic(s):
General Literature See topic collection
13
Addressing suicide risk in primary care: Cost savings associated with diverting patients from emergency departments
Type: Journal Article
Authors: Kathryn Mancini, Brittany R. Myers, Julie Pajek, Lisa Ramirez, Terry Stancin
Year: 2023
Topic(s):
Financing & Sustainability See topic collection
,
Healthcare Disparities See topic collection
,
Education & Workforce See topic collection
14
Addressing the needs of Hispanic Veterans who live in rural areas to improve suicide prevention efforts
Type: Journal Article
Authors: Magaly Freytes, Nathaniel Eliazar-Macke, Melanie Orejuela, Janet Lopez, Talia Spark, Bryann DeBeer, Magda Montague, Constance Uphold
Year: 2025
Topic(s):
Healthcare Disparities See topic collection
15
Adolescents Who Do Not Endorse Risk via the Patient Health Questionnaire Before Self-Harm or Suicide
Type: Journal Article
Authors: J. P. Flores, G. Kahn, R. B. Penfold, E. A. Stuart, B. K. Ahmedani, A. Beck, J. M. Boggs, K. J. Coleman, Y. G. Daida, F. L. Lynch, J. E. Richards, R. C. Rossom, G. E. Simon, H. C. Wilcox
Year: 2024
Abstract:

IMPORTANCE: Given that the Patient Health Questionnaire (PHQ) item 9 is commonly used to screen for risk of self-harm and suicide, it is important that clinicians recognize circumstances when at-risk adolescents may go undetected. OBJECTIVE: To understand characteristics of adolescents with a history of depression who do not endorse the PHQ item 9 before a near-term intentional self-harm event or suicide. DESIGN, SETTING, AND PARTICIPANTS: This was a retrospective cohort study design using electronic health record and claims data from January 2009 through September 2017. Settings included primary care and mental health specialty clinics across 7 integrated US health care systems. Included in the study were adolescents aged 13 to 17 years with history of depression who completed the PHQ item 9 within 30 or 90 days before self-harm or suicide. Study data were analyzed September 2022 to April 2023. EXPOSURES: Demographic, diagnostic, treatment, and health care utilization characteristics. MAIN OUTCOME(S) AND MEASURE(S): Responded "not at all" (score = 0) to PHQ item 9 regarding thoughts of death or self-harm within 30 or 90 days before self-harm or suicide. RESULTS: The study included 691 adolescents (mean [SD] age, 15.3 [1.3] years; 541 female [78.3%]) in the 30-day cohort and 1024 adolescents (mean [SD] age, 15.3 [1.3] years; 791 female [77.2%]) in the 90-day cohort. A total of 197 of 691 adolescents (29%) and 330 of 1024 adolescents (32%), respectively, scored 0 before self-harm or suicide on the PHQ item 9 in the 30- and 90-day cohorts. Adolescents seen in primary care (odds ratio [OR], 1.5; 95% CI, 1.0-2.1; P = .03) and older adolescents (OR, 1.2; 95% CI, 1.0-1.3; P = .02) had increased odds of scoring 0 within 90 days of a self-harm event or suicide, and adolescents with a history of inpatient hospitalization and a mental health diagnosis had twice the odds (OR, 2.0; 95% CI, 1.3-3.0; P = .001) of scoring 0 within 30 days. Conversely, adolescents with diagnoses of eating disorders were significantly less likely to score 0 on item 9 (OR, 0.4; 95% CI, 0.2-0.8; P = .007) within 90 days. CONCLUSIONS AND RELEVANCE: Study results suggest that older age, history of an inpatient mental health encounter, or being screened in primary care were associated with at-risk adolescents being less likely to endorse having thoughts of death and self-harm on the PHQ item 9 before a self-harm event or suicide death. As use of the PHQ becomes more widespread in practice, additional research is needed for understanding reasons why many at-risk adolescents do not endorse thoughts of death and self-harm.

Topic(s):
Healthcare Disparities See topic collection
16
Adverse Childhood Experiences and Lifetime Suicide Attempts among High-Risk Latine Individuals Entering Behavioral Health Treatment
Type: Journal Article
Authors: A. Modeste-James, T. Fitzgerald, M. D'Lppolito, J. Mateo, D. De Jesus, E. Stewart, M. Canuto, L. Lundgren
Year: 2025
Abstract:

The relationship between adverse childhood experiences (ACEs) and lifetime suicide attempts among high-risk Latine remains underexplored. This study examined the understudied intersections of ACEs, Latine ethnicity, and lifetime suicide attempts among high-risk individuals entering behavioral health treatment. This secondary analysis involved 299 Latine adults entering integrated behavioral health treatment. A multivariate logistic regression analysis was conducted to assess ACE scores and lifetime suicide attempts, controlling for social drivers of health such as housing, employment, and education. Key findings show that 28% of the sample reported lifetime suicide attempts. Multivariate analysis found that for every unit increase in ACE scores, the odds of lifetime suicide attempts increased by 21% (OR = 1.21, 95% CI [1.07, 1.38]). Additionally, those who reported being unemployed were 2.39 times more likely to have attempted suicide in their lifetime compared to their counterparts, and those who self-identified as Puerto Rican were 2.04 times more likely to report a lifetime suicide attempt. This study underscores the importance of screening for ACEs and providing services such as employment training, trauma-informed care, and suicide prevention services to Latine individuals, especially those who identify as Puerto Rican. Additional research needs to be conducted on the effects of colonization on the health and mental health of individuals of Puerto Rican descent.

Topic(s):
Healthcare Disparities See topic collection
17
Adverse outcomes in patients with a diagnosis of an eating disorder: primary care cohort study with linked secondary care and mortality records
Type: Journal Article
Authors: C. Morgan, M. J. Carr, C. A. Chew-Graham, T. W. O'Neill, R. Elvins, N. Kapur, R. T. Webb, D. M. Ashcroft
Year: 2025
Abstract:

OBJECTIVE: To examine the short and long term adverse physical and mental health outcomes, all cause mortality, and natural and unnatural deaths in individuals with a diagnosis of an eating disorder compared with a matched cohort without these disorders. DESIGN: Primary care cohort study with linked secondary care and mortality records. SETTING: English primary care electronic health records from the Clinical Practice Research Datalink, linked to Hospital Episode Statistics for hospital records and the Office for National Statistics for mortality data, 1 January 1998 to 30 November 2018. PARTICIPANTS: 24 709 patients, aged 10-44 years, with a diagnosis of an eating disorder, matched by age, sex, and general practice with up to 20 comparators without an eating disorder (n=493 001). Disorders examined were anorexia nervosa, bulimia nervosa, binge eating disorder, and all other types combined. MAIN OUTCOME MEASURES: Physical health conditions, mental health conditions, and mortality (all cause and cause specific). Hazard ratios and cumulative incidences were calculated to compare outcomes. RESULTS: Individuals with eating disorders had substantially higher risks for coded adverse physical, mental health, and mortality outcomes. Within the first year after a diagnosis of an eating disorder, these individuals were six times more likely to develop renal failure (hazard ratio 6.0, 95% confidence interval (CI) 4.2 to 8.5; excess 15 events per 10 000 individuals, 95% CI 11 to 21) and nearly seven times more likely to develop liver disease (hazard ratio 6.7, 3.8 to 11.7; excess 6 per 10 000, 4 to 11). Risks were still increased after five years (hazard ratio for renal failure 2.6, 95% CI 2.0 to 3.4; hazard ratio for liver disease 3.7, 2.3 to 6.0), with cumulative excesses of 110 (95% CI 87 to 136) and 26 (17 to 39) per 10 000 individuals at 10 years for renal failure and liver disease, respectively. Mental health coded outcomes were markedly increased in the short term for depression (hazard ratio 7.3, 95% CI 6.6 to 8.1; excess 596 per 10 000 individuals, 95% CI 545 to 650) and self-harm (hazard ratio 9.4, 8.2 to 10.7; excess 309 per 10 000, 279 to 342) at one year. Mortality was also higher: within the first year, the risk of all cause mortality was more than fourfold (hazard ratio 4.6, 95% CI 3.1 to 7.0; excess 10 per 10 000 individuals, 95% CI 7 to 15) and was fivefold for unnatural deaths (hazard ratio 5.1, 2.2 to 11.9; excess 30 per 100 000, 13 to 61). Risks persisted beyond five years (hazard ratio 2.2, 95% CI 1.8 to 2.7 for all cause mortality; hazard ratio 3.2, 1.9 to 5.4 for unnatural deaths), corresponding to 43 (95% CI 33 to 54) excess all cause deaths per 10 000 individuals and 184 (125 to 262) excess unnatural deaths per 100 000 at five years. At 10 years, 95 (95% CI 75 to 118) excess all cause deaths per 10 000 individuals and 341 (236 to 479) unnatural deaths per 100 000 were found. Suicide risk was 13.7 times higher in the first year (95% CI 4.8 to 38.8; 24 excess deaths per 100 000 individuals, 95% CI 10 to 52) and remained increased at 10 years (hazard ratio 2.7, 1.3 to 5.8), accounting for 169 (103 to 266) excess deaths per 100 000 individuals. CONCLUSIONS: Individuals with a diagnosis of an eating disorder derived from coded primary care data were more likely to have recorded adverse physical and mental health outcomes, as well as higher mortality than individuals without an eating disorder matched by age, sex, and general practice. These findings highlight the need for integrated care strategies that deal with both the physical and mental health dimensions in the management of individuals with eating disorders.

Topic(s):
Healthcare Disparities See topic collection
18
American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance
Type: Journal Article
Authors: L. Manchikanti, S. Abdi, S. Atluri, C. C. Balog, R. M. Benyamin, M. V. Boswell, K. R. Brown, B. M. Bruel, D. A. Bryce, P. A. Burks, A. W. Burton, A. K. Calodney, D. L. Caraway, K. A. Cash, P. J. Christo, K. S. Damron, S. Datta, T. R. Deer, S. Diwan, I. Eriator, F. J. Falco, B. Fellows, S. Geffert, C. G. Gharibo, S. E. Glaser, J. S. Grider, H. Hameed, M. Hameed, H. Hansen, M. E. Harned, S. M. Hayek, S. Helm II, J. A. Hirsch, J. W. Janata, A. D. Kaye, A. M. Kaye, D. S. Kloth, D. Koyyalagunta, M. Lee, Y. Malla, K. N. Manchikanti, C. D. McManus, V. Pampati, A. T. Parr, R. Pasupuleti, V. B. Patel, N. Sehgal, S. M. Silverman, V. Singh, H. S. Smith, L. T. Snook, D. R. Solanki, D. H. Tracy, R. Vallejo, B. W. Wargo, American Society of Interventional Pain Physicians
Year: 2012
Publication Place: United States
Abstract: RESULTS: Part 2 of the guidelines on responsible opioid prescribing provides the following recommendations for initiating and maintaining chronic opioid therapy of 90 days or longer. 1. A) Comprehensive assessment and documentation is recommended before initiating opioid therapy, including documentation of comprehensive history, general medical condition, psychosocial history, psychiatric status, and substance use history. ( EVIDENCE: good) B) Despite limited evidence for reliability and accuracy, screening for opioid use is recommended, as it will identify opioid abusers and reduce opioid abuse. ( EVIDENCE: limited) C) Prescription monitoring programs must be implemented, as they provide data on patterns of prescription usage, reduce prescription drug abuse or doctor shopping. ( EVIDENCE: good to fair) D) Urine drug testing (UDT) must be implemented from initiation along with subsequent adherence monitoring to decrease prescription drug abuse or illicit drug use when patients are in chronic pain management therapy. ( EVIDENCE: good) 2. A) Establish appropriate physical diagnosis and psychological diagnosis if available prior to initiating opioid therapy. ( EVIDENCE: good) B) Caution must be exercised in ordering various imaging and other evaluations, interpretation and communication with the patient, to avoid increased fear, activity restriction, requests for increased opioids, and maladaptive behaviors. ( EVIDENCE: good) C) Stratify patients into one of the 3 risk categories - low, medium, or high risk. D) A pain management consultation, may assist non-pain physicians, if high-dose opioid therapy is utilized. ( EVIDENCE: fair) 3. Essential to establish medical necessity prior to initiation or maintenance of opioid therapy. ( EVIDENCE: good) 4. Establish treatment goals of opioid therapy with regard to pain relief and improvement in function. ( EVIDENCE: good) 5. A) Long-acting opioids in high doses are recommended only in specific circumstances with severe intractable pain that is not amenable to short-acting or moderate doses of long-acting opioids, as there is no significant difference between long-acting and short-acting opioids for their effectiveness or adverse effects. ( EVIDENCE: fair) B) The relative and absolute contraindications to opioid use in chronic non-cancer pain must be evaluated including respiratory instability, acute psychiatric instability, uncontrolled suicide risk, active or history of alcohol or substance abuse, confirmed allergy to opioid agents, coadministration of drugs capable of inducing life-limiting drug interaction, concomitant use of benzodiazepines, active diversion of controlled substances, and concomitant use of heavy doses of central nervous system depressants. ( EVIDENCE: fair to limited) 6. A robust agreement which is followed by all parties is essential in initiating and maintaining opioid therapy as such agreements reduce overuse, misuse, abuse, and diversion. ( EVIDENCE: fair) 7. A) Once medical necessity is established, opioid therapy may be initiated with low doses and short-acting drugs with appropriate monitoring to provide effective relief and avoid side effects. ( EVIDENCE: fair for short-term effectiveness, limited for long-term effectiveness) B) Up to 40 mg of morphine equivalent is considered as low dose, 41 to 90 mg of morphine equivalent as a moderate dose, and greater than 91 mg of morphine equivalence as high dose. ( EVIDENCE: fair) C) In reference to long-acting opioids, titration must be carried out with caution and overdose and misuse must be avoided. ( EVIDENCE: good) 8. A) Methadone is recommended for use in late stages after failure of other opioid therapy and only by clinicians with specific training in the risks and uses. ( EVIDENCE: limited) B) Monitoring recommendation for methadone prescription is that an electrocardiogram should be obtained prior to initiation, at 30 days and yearly thereafter. ( EVIDENCE: fair) 9. In order to reduce prescription drug abuse and doctor shopping, adherence monitoring by UDT and PMDPs provide evidence that is essential to the identification of those patients who are non-compliant or abusing prescription drugs or illicit drugs. ( EVIDENCE: fair) 10. Constipation must be closely monitored and a bowel regimen be initiated as soon as deemed necessary. ( EVIDENCE: good) 11. Chronic opioid therapy may be continued, with continuous adherence monitoring, in well-selected populations, in conjunction with or after failure of other modalities of treatments with improvement in physical and functional status and minimal adverse effects. ( EVIDENCE: fair). DISCLAIMER: The guidelines are based on the best available evidence and do not constitute inflexible treatment recommendations. Due to the changing body of evidence, this document is not intended to be a "standard of care."
Topic(s):
Opioids & Substance Use See topic collection
,
Education & Workforce See topic collection
19
An integrated community and primary healthcare worker intervention to reduce stigma and improve management of common mental disorders in rural India: Protocol for the SMART Mental Health programme
Type: Journal Article
Authors: M. Daniel, P. K. Maulik, S. Kallakuri, A. Kaur, S. Devarapalli, A. Mukherjee, A. Bhattacharya, L. Billot, G. Thornicroft, D. Praveen, U. Raman, R. Sagar, S. Kant, B. Essue, S. Chatterjee, S. Saxena, A. Patel, D. Peiris
Year: 2021
Abstract:

BACKGROUND: Around 1 in 7 people in India are impacted by mental illness. The treatment gap for people with mental disorders is as high as 75-95%. Health care systems, especially in rural regions in India, face substantial challenges to address these gaps in care, and innovative strategies are needed. METHODS: We hypothesise that an intervention involving an anti-stigma campaign and a mobile-technology-based electronic decision support system will result in reduced stigma and improved mental health for adults at high risk of common mental disorders. It will be implemented as a parallel-group cluster randomised, controlled trial in 44 primary health centre clusters servicing 133 villages in rural Andhra Pradesh and Haryana. Adults aged ≥ 18 years will be screened for depression, anxiety and suicide based on Patient Health Questionnaire (PHQ-9) and Generalised Anxiety Disorders (GAD-7) scores. Two evaluation cohorts will be derived-a high-risk cohort with elevated PHQ-9, GAD-7 or suicide risk and a non-high-risk cohort comprising an equal number of people not at elevated risk based on these scores. Outcome analyses will be conducted blinded to intervention allocation. EXPECTED OUTCOMES: The primary study outcome is the difference in mean behaviour scores at 12 months in the combined 'high-risk' and 'non-high-risk' cohort and the mean difference in PHQ-9 scores at 12 months in the 'high-risk' cohort. Secondary outcomes include depression and anxiety remission rates in the high-risk cohort at 6 and 12 months, the proportion of high-risk individuals who have visited a doctor at least once in the previous 12 months, and change from baseline in mean stigma, mental health knowledge and attitude scores in the combined non-high-risk and high-risk cohort. Trial outcomes will be accompanied by detailed economic and process evaluations. SIGNIFICANCE: The findings are likely to inform policy on a low-cost scalable solution to destigmatise common mental disorders and reduce the treatment gap for under-served populations in low-and middle-income country settings. TRIAL REGISTRATION: Clinical Trial Registry India CTRI/2018/08/015355 . Registered on 16 August 2018.

Topic(s):
Healthcare Disparities See topic collection
,
Measures See topic collection
20
Anxiety and Depression Screening of Youth in Pediatric Pulmonary Hypertension Clinic: A Multi-Center, Cross-Sectional Study
Type: Journal Article
Authors: C. Parker, E. Whalen, M. A. Smith, J. Becerra, L. Stevens, C. M. Avitabile, A. Brown, M. Cash, E. O. Jackson, J. McSweeney, K. Miller-Reed, J. T. Reyes, C. Sheppard, M. P. Mullen
Year: 2025
Abstract:

Children with chronic diseases, including pulmonary hypertension (PH), have an increased risk of anxiety and depression (AD), impacting mental health (MH), and quality of life (QoL). We sought to characterize the prevalence of AD in pediatric PH and identify associated factors. We developed a prospective cross-sectional study with 10 Pediatric Pulmonary Hypertension Network (PPHNet) centers. Eligible subjects aged 12-21, diagnosed with PH, and English or Spanish speaking, completed validated AD screening questionnaires during routine outpatient clinic visits. Caregivers provided socioeconomic status (SES) data and MH history via survey. Patient demographics and clinical characteristics were analyzed using standard descriptive statistics. Eighty-eight patients were enrolled (female = 54, 61%). Forty-six (51.7%) identified at least mild symptoms of AD. Females were more likely to report AD than males (OR 2.67, 95% CI 1.11-6.61, p = 0.030). There were no significant associations between AD and PH severity, MH history, family dynamics, SES status, race, or ethnicity. Twenty-seven of those patients (58.7%) received MH education/counseling by MH professionals; ten (21.7%) were referred to MH providers, and nine patients (19.6%) were assessed for suicide safety. Adolescents with PH have a high prevalence of AD. Female patients had increased AD compared to male patients; no other predictors were linked to the prevalence of AD. Routine AD screening should be integrated into outpatient PH clinic visits with a focus on psychosocial support for young females diagnosed with PH.

Topic(s):
Healthcare Disparities See topic collection
,
Medically Unexplained Symptoms See topic collection